Development of Benzimidazole a promising scaffold against Breast cancer via in silico approaches

benzimidazole derivatives against breast cancer

Authors

  • jyoti Monga Shobhit University
  • Niladry Sekhar Ghosh Assam Downtown University
  • Minky Mukhija Ch. Devi lal College of Pharmacy, Jagadhri
  • Sonia Kamboj Ch. Devi lal College of Pharmacy, Jagadhri
  • Ranjit Singh Shobhit University

Keywords:

Breast cancer, Molecular Modeling, Computer simulations, Docking, Molecular Targets, heterocyclic compounds, clinical drugs

Abstract

Computational techniques offer useful tools for lead identification, optimization, and target selection in the search for many therapeutic candidates for breast cancer. It is well known that benzimidazole and its derivatives are important players in the development of novel anticancer drugs. Computational methods help to streamline the drug discovery process, reduce costs, and increase the chances of identifying effective treatments for this complex disease. As is commonly accepted, discovering new drugs is a difficult, slow, and affluent process. According to estimates, the typical drug development pipeline takes 12 years and costs $2.7 billion to produce a new drug. The pharmaceutical sector is struggling to find a solution to the difficult and pressing issue of how to minimize research costs while expediting the development of new therapies. The development of computer-aided drug discovery (CADD), is a potent and optimistic technique for developing medications rapidly, inexpensively, and efficiently. Recent advances in computational drug discovery technologies have substantially influenced the development of drugs to treat Breast Cancer. To identify leads, computational methods offer useful tools. In the present study, a computational study on benzimidazoles and their derivatives against Breast Cancer targets have been provided.

URN: NBN: sciencein.jist.2024.v12.714

Downloads

Download data is not yet available.

Author Biographies

  • jyoti Monga, Shobhit University

    Adarsh Vijendra Institute of Pharmaceutical Sciences
    and
    Ch. Devi lal College of Pharmacy, Jagadhri

     

  • Niladry Sekhar Ghosh, Assam Downtown University

    Faculty of Pharmaceutical Sciences

  • Ranjit Singh, Shobhit University

    Adarsh Vijendra Institute of Pharmaceutical Sciences

Downloads

Published

2023-09-04

Issue

Section

Biomedical and Pharmaceutical Sciences

URN

How to Cite

Monga, jyoti, Ghosh, N. S., Mukhija, M., Kamboj, S., & Singh, R. (2023). Development of Benzimidazole a promising scaffold against Breast cancer via in silico approaches. Journal of Integrated Science and Technology, 12(1), 714. https://pubs.thesciencein.org/journal/index.php/jist/article/view/a714

Similar Articles

1-10 of 66

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)